T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 6,499,835 shares of IMCR stock, worth $211 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
6,499,835
Previous 2,992,273
117.22%
Holding current value
$211 Million
Previous $101 Million
99.53%
% of portfolio
0.12%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding IMCR
# of Institutions
141Shares Held
41.4MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$229 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$158 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$80.1 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$70 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY1.52MShares$49.1 Million0.51% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.42B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...